SPDL1 and non-small cell lung carcinoma: In conclusion, our study demonstrated that sPD-1 and sPD-L1 levels can be used as a potential biomarker for lung cancer screening, prediction of the stage, and besides to detect recurrences and/or metastases following resection in NSCLC.